VALHALLA – New York Medical College
in Valhalla has its first three tenants for its recently launched biotechnology
incubator, BioInc@NYMC. The program’s mission is to find new ways
to prevent and treat human disease and disability.
The tenants include Conversion Energy Enterprises, a corporation that
develops and prototypes laser products for medical applications; MB Group
USA, a supplier of products derived from rare fruits for health purposes
and MOE Medical Devices, LLC, a maker of cold electrical plasma therapeutics.
BioInc@NYMC occupies a 10,000 square foot wing of a 129,000 square foot campus building. An initial build-out of 4,500 SF with finished laboratories, offices and shared infrastructure is ready for immediate occupancy. Development of the remaining space is planned as initial spaces are filed.
“Our first three tenants demonstrate that the promise of the incubator is being fulfilled: BioInc@NYMC is simultaneously generating and disseminating new knowledge about biomedicine while serving as a job creation engine and a source for Westchester’s economic development,” said Chancellor and CEO Dr. Edward Halperin.
